Consumer groups argue that parallel trading leads to cheaper prices but trade mark owners say it jeopardizes their long-term relationships with both distributors and consumers. Peter Hallett of ...
Parallel trade may be a bane for drug supplies in low-cost countries, but it's been a boon for Andreas Mohringer and his company, EurimPharm Arzneimittel. As Bloomberg reports, Mohringer has made a ...
The shipment of bona fide pharmaceutical drugs into Britain from Europe may cost the UK pharmaceutical industry more than £770million a year. The net effect on the UK economy as a whole, taking into ...
The fiscal mess in Greece has been hard enough on drugmakers, not to mention drug supplies for patients. But the government's attempts to budget-cut its way into a solution has put an even bigger kink ...
LONDON, May 14 (Reuters) - Pfizer Inc. , the world's largest drugmaker, locked horns with European drug wholesalers on Monday, accusing companies engaged in so-called "parallel trade" of fuelling ...
The European Commission welcomes today's ruling of the European Court of Justice (ECJ) on the supply quotas for pharmaceuticals on the Greek wholesale market (Joined Cases C-468/06, C-469/06, C-470/06 ...
SALEM: Tapioca farmers in Salem have alleged that weak enforcement of bylaws by leading co-operative SAGOSERVE and the Food ...
European Union antitrust regulators are investigating whether pharmaceutical companies may thwart sales by traders who profit from differences in drug prices between nations. The EU has started a ...
A new study by the London School of Economics questions the widely held view that parallel trade benefits national medicine budgets and patients. Instead, it argues that the majority of benefits go to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results